Koshinski Asset Management, Inc. Pet Vivo Holdings, Inc. Transaction History

Koshinski Asset Management, Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 29, 2024	BUY	$0.6 - $2.18 $10,800 - $39,240	18,000 New	18,000 $19,000
Q1 2023 Apr 12, 2023	BUY	$2.2 - $3.4 $6,600 - $10,200	3,000 Added 20.0%	18,000 $49,000
Q4 2022 Jan 24, 2023	BUY	$1.85 - $2.69 $9,250 - $13,450	5,000 Added 50.0%	15,000 $0
Q2 2022 Jul 12, 2022	BUY	$1.3 - $2.63 $6,713 - $13,581	5,164 Added 106.78%	10,000 $16,000
Q1 2022 Apr 20, 2022	BUY	$1.25 - $3.97 $1,045 - $3,318	836 Added 20.9%	4,836 $9.87 Million
Q4 2021 Jan 14, 2022	SELL	$2.4 - $5.01 $1,610 - $3,361	-671 Reduced 14.37%	4,000 $15.1 Million
Q3 2021 Oct 12, 2021	BUY	$2.62 - $9.25 $12,238 - $43,206	4,671 New	4,671 $0

Ticker PETV
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 10,072,000
Market Cap $7.45M
Description
PetVivo Holdings, Inc., a biomedical device company, engages in the manufacturing, commercializing, and licensing of medical devices and biomaterials for the treatment of afflictions and diseases in animals. Its lead product is Spryng, a veterinarian-administered, intraarticular injection for the management of lameness and other joint affliction...

Get notified when there are updates to the investment portfolio of Koshinski Asset Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Koshinski Asset Management, Inc. with notifications on news.